Validation of the vitiligo-specific quality-of-life instrument (VitiQoL) for the Turkish language: the VitiQoL-TR study

被引：0
作者：
Kurt, Birgul Ozkesici [1 ]
Sayili, Ugurcan [2 ]
Durmus, Dila Cagla Ocal
Kayaalti, Ahmet [1 ]
Cetinkaya, Pinar Ozdemir [3 ]
Aksu, Asli [1 ]
Kundu, Roopal V. [4 ]
Altunay, Ilknur Kivanc [1 ]
机构：
[1] Univ Hlth Sci, Hamidiye Etfal Training & Res Hosp, Hamidiye Fac Med, Dept Dermatol,Clin Dermatol, Seyrantepe Campus,Huzur Mah Cumhuriyet & Demokrasi, TR-34396 Istanbul, Turkiye
[2] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Publ Hlth, Istanbul, Turkiye
[3] Hamidiye Etfal Training & Res Hosp, Dermatol Clin, Seyrantepe Campus, Istanbul, Turkiye
[4] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA
来源：
ARCHIVES OF DERMATOLOGICAL RESEARCH | 2025年 / 317卷 / 01期
关键词：
Health related quality of life; Reliability; Validation; Vitiligo; Vitiligo-specific quality-of-life; SKIN-DISEASE; VERSION; RELIABILITY; VALIDITY; INDEX;
D O I：
10.1007/s00403-025-03968-8
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Vitiligo is a generally asymptomatic acquired depigmentation disorder, limiting the utility of general dermatology quality of life (QoL) scales that may not adequately reflect the psychosocial burden experienced by patients. The aim of our study was to translate the vitiligo-specific quality-of-life instrument (VitiQoL) with maximum score of 90, into Turkish language, and to culturally adapt and validate it for use in the Turkish population. The VitiQoL was initially cross-culturally adapted to Turkish through forward-backward translation. The Turkish version of the VitiQoL together with the dermatology life quality index (DLQI) and the Skindex-16 scale were applied to Turkish vitiligo patients. A total of 148 consecutive volunteer vitiligo patients were included in the study. The internal consistency of the Turkish version of the VitiQoL was excellent (Cronbach's alpha = 0.915). Since the Turkish version of the VitiQoL item 13 had a corrected item-total correlation lower than 0.3 (0.264), it was removed from the survey. VitiQoL-TR includes 14 items, with the removal of item 13 (Cronbach's alpha = 0.922). Exploratory factor analyses revealed two distinct factors within the VitiQoL scale: participation limitation and stigma. Forty-six (31.08%) of the participants completed the VitiQoL-TR twice, 10-14 days apart. The test and retest scores of the VitiQoL-TR had a strong significant correlation (r = 0.883; p < 0.001). The intraclass correlation coefficient was 0.939. There was a strong significant correlation between the VitiQoL-TR score and the Skindex-16 score (r = 0.848; p < 0.001), and a moderate significant correlation with the DLQI score (r = 0.696; p < 0.001) thus confirming the convergent validity. In conclusion, the maximum value of the scale is 84 instead of 90. This should be taken into consideration when conducting international studies and comparing international data. The VitiQoL-TR is a valid and reliable health-related QoL tool for assessing the QoL of Turkish vitiligo patients.
引用
收藏
页数：11
相关论文
共 23 条
  • [1] Alghamdi K.M., Kumar A., Taieb A., Ezzedine K., Assessment methods for the evaluation of vitiligo, J Eur Acad Dermatol Venereol, 26, pp. 1463-1471, (2012)
  • [2] Balkrishnan R., McMichael A.J., Camacho F.T., Saltzberg F., Housman T.S., Grummer S., Feldman S.R., Chren M.M., Development and validation of a health-related quality of life instrument for women with melasma, Br J Dermatol, 149, pp. 572-577, (2003)
  • [3] Boza J.C., Kundu R.V., Fabbrin A., Horn R., Giongo N., Cestari T.F., Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese, An Bras Dermatol, 90, pp. 358-362, (2015)
  • [4] Chren M.M., Lasek R.J., Quinn L.M., Mostow E.N., Zyzanski S.J., Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness, J Invest Dermatol, 107, pp. 707-713, (1996)
  • [5] Chren M.M., Lasek R.J., Flocke S.A., Zyzanski S.J., Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases, Arch Dermatol, 133, pp. 1433-1440, (1997)
  • [6] Chren M.M., Lasek R.J., Sahay A.P., Sands L.P., Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases, J Cutan Med Surg, 5, pp. 105-110, (2001)
  • [7] Chren M.M., The Skindex instruments to measure the effects of skin disease on quality of life, Dermatol Clin, 30, pp. 231-236, (2012)
  • [8] DeVellis R., Scale development: theory and applications, 4th, (2016)
  • [9] Fehnel S.E., McLeod L.D., Brandman J., Arbit D.I., McLaughlin-Miley C.J., Coombs J.H., Martin A.R., Girman C.J., Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials, Qual Life Res, 11, pp. 809-816, (2002)
  • [10] Finlay A.Y., Khan G.K., Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use, Clin Exp Dermatol, 19, pp. 210-216, (1994)
123